Organ transplants are imperative for saving patient lives in cases of negligible outcomes from surgeries or medications. The success of these transplants have shown success in recent years in children and adults with chronic diseases. Transplant diagnostic solutions are tests conducted for displaying the compatibility ratio between patients and organs. The global transplant diagnostics market report by Market Research Future (MRFR) highlights the various trends, opportunities, and challenges industry participants can face in the period between 2018 and 2023.

The global transplant diagnostics market share is slated to display a CAGR of 7.80% from 2018 to 2023 (forecast period). It can touch a value of USD 2,074.65 million by 2023. The inflow of capital for research and development purposes for improving the accuracy of transplant diagnostic tests can drive the market growth exponentially. Public-private partnerships are likely to expedite the rate of R&D due to subsidies and attractive incentives. Large number of transplantation procedures are likely to elicit the need for transplant diagnostic tests at clinics and hospitals. According to a collaboration between World Health Organization (WHO) and Organización Nacional de Trasplantes, 126,670 organs were transplanted in 2015.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1324

Rise of medical tourism in countries of Asia Pacific are expected to influence the market demand due to low-cost surgeries being provided to patients unable to afford the treatments costs in developed economies. Low awareness levels among patients and strict regulations pertaining to its use are obstacles faced by the market.

Competition Outlook

Becton Dickinson and Company, QIAGEN N.V, F. Hoffmann La Roche Ltd., bioMérieux S.A., Illumina, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and others are noteworthy participants of the global transplant diagnostics market.

Segmentation

The global transplant diagnostics market is segmented by product & service, screening type, application, organ, and end-user.

By product & service, the transplant diagnostics market comprises instruments, reagents & consumables, and software & services. The reagents and consumables segment accounted for a large market share in 2017. It can continue to be lucrative for the market during the forecast period. The need for diagnostic tests for ascertaining the histocompatibility as well as detection of human leukocyte antigens (HLA) can drive the segment growth till 2023.
By Types of screening include pre-transplant and post-transplant screening. The pre-transplant screening type is expected to be highly successful till 2023 due to the need for tests showcasing the success of transplants. It had a valuation of USD 819.04 million in 2017.
By Applications include research applications, diagnostic applications, and others. Diagnostic applications are touted to dominate in the global market till the end of the forecast period. MRFR has forecasted the segment to perform well due to government policies advocating the use of tests for successful surgical outcomes.
Various types of organs discussed in the market report include pancreas, kidney, heart, lung, liver, and others. The kidney segment was valued at USD 819.04 million in 2017 and can command a high demand till 2023.
By End-users of the product comprises hospitals and transplant centers, commercial service providers, research laboratories & academic institutes, and others. The hospitals and transplant centers segment is likely to be the biggest end-user till the end of the assessment period owing to demand for diagnosis of infectious diseases.
Regional Analysis

Asia Pacific (APAC), the Americas, Europe, and the Middle East & Africa (MEA) are the regions discussed with respect to the market report.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/transplant-diagnostics-market-1324

The Americas will continue to dominate the market till 2023 due to progress in HLA tests, adoption of automation in testing, and prevalence of chronic diseases. Europe is touted to be the second largest region for the global transplant diagnostics market due to policies developed by international health organizations for creating awareness among the populace.

The APAC region can experience a stellar growth rate during the forecast timespan owing to large number of patients requiring transplants and the large number of doctors available for surgeries. Investments in in-vitro tissue engineering and stem cells can bode well for the region in the coming years.